These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9281137)

  • 41. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The endogenous intoxication syndrome and the procedure for detoxication therapy in the treatment of suppurative diseases of the face and neck].
    Gubin MA; Kharitonov IuM; El'kova NL; Korolinskiĭ SA; Motorin SA; Stegantsov VA
    Stomatologiia (Mosk); 1996; 75(4):23-7. PubMed ID: 8992658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The problem of the antibacterial therapy of inflammatory diseases of the maxillofacial area].
    Ushakov RV; Tsarev VN; Romanov AE
    Stomatologiia (Mosk); 1996; Spec No():84. PubMed ID: 9281186
    [No Abstract]   [Full Text] [Related]  

  • 44. [Physical therapy of otorhinolaryngologic inflammatory diseases].
    Filatov VF
    Vestn Otorinolaringol; 1995; (2):5-8. PubMed ID: 7785158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
    Shimchenko PIa; Morozov VG; Khavinson VKh; Orlov VS
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):94-7. PubMed ID: 6895567
    [No Abstract]   [Full Text] [Related]  

  • 46. [The structural and etiological characteristics of inflammatory diseases of the maxillofacial area].
    Kislykh FI; Urazova IV
    Stomatologiia (Mosk); 1996; Spec No():61-2. PubMed ID: 9281154
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of inflammatory pyodestructive processes of the oral cavity, maxillofacial area, and neck by laser and magnetic-laser exposure of the carotid sinus using the Optodan laser apparatus].
    Zhizhina NA; Prokhonchukov AA; Vakhtin VI; Geniuk VIa
    Stomatologiia (Mosk); 2003; 82(3):32-7. PubMed ID: 12841139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of portable thermal-infusion dosage devices (DF-1) for the regional intra-arterial administration of antibiotics in the combined treatment of patients with inflammatory processes of the maxillofacial area].
    Sukachev VA; Semkin VA; Abrosimov AI; Klimchenko IuG
    Stomatologiia (Mosk); 1988; 67(6):8-10. PubMed ID: 3238733
    [No Abstract]   [Full Text] [Related]  

  • 49. [The characteristics of the clinical course of inflammatory diseases of the maxillofacial area in children].
    Roginskiĭ VV; Korinskaia NN
    Stomatologiia (Mosk); 1996; 75(6):48-52. PubMed ID: 9214038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of the UV irradiation of autologous blood on the humoral link in the immune response of patients with chronic inflammatory processes].
    Ivanov EM; Kapshienko IN; Tril' NM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):45-7. PubMed ID: 2711636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The effect of plasmosorption on the healing dynamics of postoperative wounds in patients with suppurative-inflammatory processes of the maxillofacial area and diabetes mellitus].
    Zuev VP; Alekseeva AN; Pchelin VG
    Stomatologiia (Mosk); 1995; 74(3):36-7. PubMed ID: 7570695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The acute inflammatory response. Mechanisms and therapeutic possibilities].
    Pedersen JL; Kehlet H
    Ugeskr Laeger; 1996 Oct; 158(41):5754-61. PubMed ID: 8928263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunocorrection in the combined treatment of patients with sialoadenitis].
    Pinelis IS; Skurlatov AG
    Stomatologiia (Mosk); 1997; 76(1):32-3. PubMed ID: 9148512
    [No Abstract]   [Full Text] [Related]  

  • 54. [The physiological adaptation functions of cellular and humoral immunity in patients with phlegmons of the maxillofacial area].
    Iunuskhodzhaev E; Bazhanov NN; Belokrinitskiĭ DV; Shelepin AA
    Stomatologiia (Mosk); 1989; 68(2):23-7. PubMed ID: 2749813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The efficacy of using hyperbaric oxygenation in different forms of an inflammatory process in the maxillofacial area].
    Kurakin AV; Karapetian IS; Volozhin AI; Sel'tsovskaia GD; Sudorgin SS; Asnina SA; Smirnova EN; Afanas'eva EA
    Stomatologiia (Mosk); 1993; 72(2):30-2. PubMed ID: 8048124
    [No Abstract]   [Full Text] [Related]  

  • 56. Current Therapy in Pediatric Oral and Maxillofacial Pathology.
    Kolokythas A; Miloro M
    Oral Maxillofac Surg Clin North Am; 2016 Feb; 28(1):ix-x. PubMed ID: 26614706
    [No Abstract]   [Full Text] [Related]  

  • 57. [The role trauma as a factor in the development of infection].
    Mposinakou M
    Stomatologia (Athenai); 1978; 35(4):183-91. PubMed ID: 279132
    [No Abstract]   [Full Text] [Related]  

  • 58. [The importance of the immunogram for the prognosis of the course of odontogenic inflammatory diseases and of the performance of immunotherapy].
    Lebedev KA; Poniakina ID
    Stomatologiia (Mosk); 1996; Spec No():65. PubMed ID: 9281159
    [No Abstract]   [Full Text] [Related]  

  • 59. [Combined treatment of odontogenic inflammatory processes using ultrasound and wide-spectrum laser radiation].
    Bazhanov NN; Mukhsinov ME; Aleksandrov MT; Kasymov AI
    Stomatologiia (Mosk); 1989; 68(1):39-41. PubMed ID: 2749789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The microbial flora and humoral protective factors in odontogenic inflammations in the maxillofacial area].
    Khazanova VV; Zemskaia EA; Dmitrieva NA
    Stomatologiia (Mosk); 1994; 73(1):17-9. PubMed ID: 8191510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.